EAN News

The Israeli Neurological Association held the first EAN Day in Israel on December 10, a day prior to its Annual Conference. We were honored to host several prominent speakers from the European community of neurologists, who shared their current views with local neurologists in beautiful surroundings and convivial atmosphere. Prof. Philip Scheltens from the Alzheimer Center of VU University Medical Center in Amsterdam discussed recent developments in diagnostics of Alzheimer's disease.

    by Professor Dafin Mureşanu       Specialists in neurology and psychiatry from Moscow and many regions of Russia  and eminent international speakers gathered in Moscow for a multidisciplinary conference on “Advances In Neuroscience And New Strategies For… Continue Reading

In December European Academy of Neurology and European Stroke Organization organized in collaboration with Lupin Pharmaceuticals the 9th Knowledge Exchange Programme Conference in Mumbai.

The Moroccan Society of Neurology (MSN) was very pleased to organise with the European Academy of Neurology (EAN) the EAN Day on the margins of the Maghrebian Congress of Neurology, held in the beautiful and charming city of Marrakech.

EANpages is the electronic news tool of EAN reporting on what happens in the neurological and allied-disciplines field, in the EAN community, and providing informed opinions on different scientific and healthcare related topics in neurology. The EANpages Editor-in-Chief is expected… Continue Reading

8th Winter Course on Movement Disorders 54th Turkish National Neurology Congress

In Europe, there are approximately 740 million people, most of whom experience an episode of severe pain at some point in their life. For approximately 20 percent, that pain is chronic – episodic, persistent, or variable. In other words, today… Continue Reading

The Sixty-eight session of the World Health Organisation Regional Committee for Europe took place in Rome, Italy (16 – 20 September, 2018).                   Health ministers and high-level representatives of the 53 Member States… Continue Reading

he Congress will begin each morning and afternoon with Plenary Sessions providing overviews of the phenomenology, pathophysiology, and current diagnostic and therapeutic strategies of various movement disorders. These sessions will be followed by Parallel Tracks, permitting participants to select specific diagnostic or therapeutic areas for more concentrated study.

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

The Guideline will address important areas of dementia management where the medical doctor plays a pivotal role, which includes treatment of epilepsy in dementia, pain in dementia, treatment with antipsychotics in dementia, vascular risk factors in dementia and systematic medical follow-up in dementia.